Lewy Body Dementia Treatment Market Poised for Growth Amid Rising Neurological Disorder Diagnoses
The global Lewy Body Dementia (LBD) treatment market is experiencing notable growth, driven by increasing awareness, advancements in diagnostic techniques, and the development of targeted therapies. As the third most common form of dementia after Alzheimer's and Parkinson's diseases, LBD affects approximately 1.4 million individuals in the United States alone, with numbers expected to rise due...
0 Comments 0 Shares 1K Views 0 Reviews